Michael Byrne

Person

Natick, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
- Patent number 11,279,934
- Issue date Mar 22, 2022
- Phio Pharmaceuticals Corp.
- Michael Byrne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
- Patent number 11,001,845
- Issue date May 11, 2021
- Phio Pharmaceuticals Corp.
- James Cardia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating neurological disorders using a synergistic sma...
- Patent number 10,808,247
- Issue date Oct 20, 2020
- Phio Pharmaceuticals Corp.
- Michael Byrne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20250051778
- Publication date Feb 13, 2025
- WAVE LIFE SCIENCES LTD.
- Michael John Byrne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20230145795
- Publication date May 11, 2023
- WAVE LIFE SCIENCES LTD.
- Michael John Byrne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1)
- Publication number 20180195072
- Publication date Jul 12, 2018
- RXi Pharmaceuticals Corporation
- James Cardia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING NEUROLOGICAL DISORDERS USING A SYNERGISTIC SMA...
- Publication number 20180195066
- Publication date Jul 12, 2018
- RXi Pharmaceuticals Corporation
- Michael Byrne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER USING NUCLEIC ACIDS TARGETING MDM2 OR MYCN
- Publication number 20170051288
- Publication date Feb 23, 2017
- RXi Pharmaceuticals Corporation
- Michael Byrne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZIN...
- Publication number 20170051290
- Publication date Feb 23, 2017
- RXi Pharmaceuticals Corporation
- Michael Byrne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Michael Byrne

Person

Patents Grantslast 30 patents

Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

Methods for treating neurological disorders using a synergistic sma...

Patents Applicationslast 30 patents

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1)

METHODS FOR TREATING NEUROLOGICAL DISORDERS USING A SYNERGISTIC SMA...

METHODS FOR TREATING CANCER USING NUCLEIC ACIDS TARGETING MDM2 OR MYCN

METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZIN...